AVEO Pharmaceuticals, Inc.
AVEO
AVEO was delisted on the 19th of January, 2023.
49 hedge funds and large institutions have $22.5M invested in AVEO Pharmaceuticals, Inc. in 2015 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 6 reducing their positions, and 11 closing their positions.
183% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 6
78% more capital invested
Capital invested by funds: $12.6M → $22.5M (+$9.83M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4% less funds holding
Funds holding: 51 → 49 (-2)
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $116K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$656K |
| 2 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$649K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$281K |
| 4 |
SIM
Spark Investment Management
New York
|
+$160K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
+$145K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$886K |
| 2 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$562K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$61K |
| 4 |
Millennium Management
New York
|
-$55K |
| 5 |
TI
Telemetry Investments
New York
|
-$37K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VKH
51
Virtu KCG Holdings
New York
| – | -$61K | -7,308 | Closed |
|
|
52
Millennium Management
New York
| – | -$55K | -6,513 | Closed |
|
|
TI
53
Telemetry Investments
New York
| – | -$37K | -4,360 | Closed |
|
|
CS
54
Credit Suisse
Zurich,
Switzerland
| – | -$29K | -3,468 | Closed |
|
|
BCM
55
Bienville Capital Management
New York
| – | -$17K | -2,000 | Closed |
|
|
CAG
56
Crestwood Advisors Group
Boston,
Massachusetts
| – | -$13K | -1,506 | Closed |
|
|
FCI
57
Financial Counselors Inc
Overland Park,
Kansas
| – | -$11K | -1,300 | Closed |
|
58
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$8K | -1,000 | Closed |
|
|
TC
59
Travelers Companies
Saint Paul,
Minnesota
| – | -$2K | -287 | Closed |
|
60
Citigroup
New York
| – | -$1K | -100 | Closed |
|
AVEO Hedge Fund Activity: Q1 2015 in Review
49 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in AVEO Pharmaceuticals, Inc. (AVEO) for Q1 2015, worth a combined $22.5M — up 78% from $12.6M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of AVEO and 9 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 17 added.
The largest buyer was Renaissance Technologies, adding an estimated $656K. The largest seller was D.E. Shaw & Co, cutting an estimated $886K.
- 49 institutional investors held AVEO Pharmaceuticals, Inc. (AVEO) as of Q1 2015, down from 51 in Q4 2014.
- Funds reported $22.5M of AVEO Pharmaceuticals, Inc. stock for Q1 2015, up 78% quarter-over-quarter.
- 9 funds opened new AVEO Pharmaceuticals, Inc. positions in Q1 2015 and 11 closed out, a net change of -2 holders.
- The largest AVEO Pharmaceuticals, Inc. buyer in Q1 2015 was Renaissance Technologies, an estimated $656K added.
- The largest AVEO Pharmaceuticals, Inc. seller in Q1 2015 was D.E. Shaw & Co, an estimated $886K sold.
Based on aggregated 13F filings for Q1 2015.